Breaking News
0

Novo Nordisk A/S Class B (NOVOb)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
296.7 -3.5    -1.17%
03:50:42 - Real-time CFD Data. Currency in DKK ( Disclaimer )
Type: Equity
Market: Denmark
ISIN: DK0060534915 
S/N: 1912564000
  • Prev. Close: 300.2
  • Open: 296.8
  • Day's Range: 294.1 - 297.1
Novo Nordisk B 296.7 -3.5 -1.17%

NOVOb Overview

 
Information about the Novo Nordisk A/S Class B Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close300.2
Day's Range294.1 - 297.1
Revenue110.09B
Open296.8
52 wk Range265.1 - 354.8
EPS15.97
Volume576,316
Market Cap544.89B
Dividend (Yield)7.85 (2.62%)
Average Vol. (3m)2,994,085
P/E Ratio17.84
Beta1.42
1-Year Change - 8.98%
Shares Outstanding2,394,000,000
Next Earnings DateFeb 01, 2019
What is your sentiment on Novo Nordisk B?
or
Vote to see community's results!

Novo Nordisk A/S Class B News


Novo Nordisk A/S Class B Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Strong Sell Sell
Technical Indicators Strong Sell Strong Sell Strong Sell Strong Sell Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Bullish doji Star 1H Current
Bullish Hammer 5H Current
Bullish Hammer 1D Current
Dragonfly Doji 1D Current
Completed Patterns
Downside Gap Three Methods 1M 1 Nov 18
Engulfing Bearish 1W 1 Dec 02, 2018
Falling Three Methods 1H 1 Dec 11, 2018 10:00AM

Novo Nordisk A/S Class B Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  Real-time CFD 296.7 - - - -1.17% DKK 03:50:42  
  Copenhagen 296.50 296.65 296.80 576,316 -1.23% DKK 03:50:00  
  BATS Europe 296.6 296.7 296.8 84,738 -1.22% DKK 03:50:30  
  NYSE 45.20 0.00 0.00 1,787,765 -1.63% USD 11/12  
  London 296.52 290.75 302.60 377 -1.93% DKK 03:43:07  
  Mexico 938.570 0.000 0.000 0 +0.00% MXN 10/12  
  Switzerland 45.875 0.000 0.000 0 +0.00% CHF 11/12  
  Xetra 39.5000 39.5000 40.0000 25 -2.23% EUR 03:04:00  
  Dusseldorf 37.435 37.305 37.395 0 0.00% EUR 30/10  
  Berlin 39.980 39.675 39.725 0 -0.55% EUR 02:01:00  
  Xetra 39.73 39.65 39.74 3,678 -1.10% EUR 03:27:00  
  Berlin 39.800 39.800 39.900 0 -1.49% EUR 02:08:00  
  Stuttgart 40.500 37.335 37.355 0 +2.16% EUR 10/12  
  Munich 40.115 39.645 39.740 0 -0.66% EUR 02:00:00  
  Frankfurt 39.77 39.65 39.74 105 -1.61% EUR 03:25:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 168.63 171.79 167.00 -0.97 -0.57% 47.28M 11/12  
  Alphabet A 1,061.65 1,070.40 1,050.10 +8.47 +0.80% 1.69M 11/12  
  Facebook 142.08 143.88 141.10 +0.23 +0.16% 20.30M 11/12  
  Amazon.com 1,643.24 1,679.47 1,619.60 +2.21 +0.13% 6.24M 11/12  
  Bank of America 24.58 25.40 24.53 -0.18 -0.73% 78.55M 11/12  
  Tesla 366.76 372.17 360.23 +1.61 +0.44% 6.31M 11/12  
  Microsoft 108.59 110.95 107.44 +1.00 +0.93% 42.38M 11/12  
  Exxon Mobil 76.68 77.80 75.68 +0.14 +0.18% 15.74M 11/12  
  Alibaba 151.83 156.24 150.90 +0.40 +0.26% 13.65M 11/12  
  Goldman Sachs 176.80 184.43 175.45 -2.03 -1.14% 4.71M 11/12  

Novo Nordisk A/S Class B Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

43161

Equity Type

ORD

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $2000 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NOVOb Comments

Write your thoughts about Novo Nordisk A/S Class B
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Manbear Pig
Manbear Pig Feb 17, 2017 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Extremely bullish double bottom pattern and fibbonacci retracement with convergence of relative strenght index upwards
Reply
1 0
Juan Francisco Olmos
Juan Francisco Olmos Mar 31, 2014 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Comenté hace unos meses que es un valor muy sólido, que lo veríamos pronto en 200 $ (que con el split son 40 $), pues bien, ha superado mis expectativas y está en 45 $.... me aventuro a pronosticar que cerrará el año en torno a los 50 $. Saludos
Reply
0 0
Juan Francisco Olmos
Juan Francisco Olmos Mar 31, 2014 4:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Comenté hace unos meses que es un valor muy sólido, que lo veríamos pronto en 200 $ (que con el split son 40 $), pues bien, ha superado mis expectativas y está en 45 $.... me aventuro a pronosticar que cerrará el año en torno a los 50 $. Saludos
Reply
0 0
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email